Our research demonstrates that activated pDCs can kill breast cancer cells in vitro through TNF-related apoptosis-inducing ligand (TRAIL) and Granzyme B. In our experiments IMQ was more effective than CpG. This evidence concerns the gene GZMB and breast cancer.